Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.
GSK invests $270M into vaccine manufacturing in Belgium
GSK is investing about $270 million (€250 million) to build out and expand its vaccine manufacturing facilities in Wavre, Belgium. The plant is expected to
September 2, 2023